Condition: Alcoholic Liver Disease · Severe Alcoholic Hepatitis · Alcoholic Cirrhosis · Sponsor: University Hospital, Lille
Alcoholic hepatitis carries a risk of high mortality at short term, especially in its severe form. Its diagnosis is confirmed by liver biopsy. The prevalence of alcoholic hepatitis, severe or not severe, is poorly known and prospective data are needed. The present observational study aims to define the prevalence of alcoholic hepatitis among patients admitted for jaundice and determine their outcome according to the severity. Survival and markers of liver dysfunction will be assessed. A biobank including genetic samples will be created to identify the disease profile in terms of inflammation and regeneration. The performance of non-invasive criteria for diagnosis will also be studied.
This description comes directly from the study's public registry record.
Alexandre Louvet, MD,PhD · 03 20 44 55 97 · alexandre.louvet@chru-lille.fr
Always discuss trial participation with your own doctor first.
| Chr Angers | Angers, France | Recruiting |
| Chru Besancon | Besançon, France | Recruiting |
| Hôpital Jean Verdier, AH-HP | Bondy, France | Recruiting |
| Centre Hospitalier Universitaire | Caen, France | Recruiting |
| Hopital Nord - Chu38 - La Tronche | La Tronche, France | Recruiting |
| Hôpital Claude Huriez, CHU | Lille, France | Recruiting |
| Association Hopital Saint Joseph - Marseille | Marseille, France | Recruiting |
| Chu Montpellier | Montpellier, France | Recruiting |
| Hu Est Parisien Site St Antoine Aphp - Paris 12 | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04106518